Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (N-Term) Peptid
PARK2
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
-
- Target Alle Parkin (PARK2) Produkte
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- 17 amino acids near the amino terminus of human PARK2.
-
-
- Applikationshinweise
- The peptide is used for blocking the activity of PARK2 Antibody . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚,C.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Rekonstitution
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Konzentration
- 200 μg/mL
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store PARK2 Peptide at -20°C, stable for one year.
- Haltbarkeit
- 12 months
-
- Target
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Synonyme
- CG10523 Peptide, Dmel\\CG10523 Peptide, Dpark Peptide, SD01679 Peptide, dpk Peptide, AR-JP Peptide, LPRS2 Peptide, PDJ Peptide, PRKN Peptide, Park Peptide, Prkn Peptide, si:ch211-123f21.1 Peptide, zgc:112390 Peptide, pdr-1 Peptide, PARK2 Peptide, parkin Peptide, parkin RBR E3 ubiquitin protein ligase Peptide, Parkinson disease (autosomal recessive, juvenile) 2, parkin Peptide, park Peptide, PRKN Peptide, Prkn Peptide, prkn Peptide, CpipJ_CPIJ014867 Peptide, Park2 Peptide
- Gen-ID
- 5071
- NCBI Accession
- NP_004553
- OMIM
- 169790969
- UniProt
- O60260
-
Sie sind hier:
